Programmed Death Receptor-1 Blocking Antibody [EPC]

Programmed Death Receptor-1 Blocking Antibody [EPC] was reported 98590 times

Drugs of the Programmed Death Receptor-1 Blocking Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 IMMUNE-MEDIATED ENDOCRINOPATHY 145 0.9667
1 IMMUNE-MEDIATED UVEITIS 173 0.9454
2 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 752 0.9435
3 IMMUNE-MEDIATED HYPERTHYROIDISM 239 0.9409
4 IMMUNE-MEDIATED THYROIDITIS 463 0.9372
5 IMMUNE-MEDIATED HYPOTHYROIDISM 1044 0.9255
6 IMMUNE-MEDIATED GASTRITIS 177 0.9219
7 IMMUNE-MEDIATED HYPOPHYSITIS 414 0.9180
8 IMMUNE-MEDIATED ARTHRITIS 341 0.8950
9 IMMUNE-MEDIATED RENAL DISORDER 368 0.8889
10 IMMUNE-MEDIATED CHOLANGITIS 319 0.8886
11 IMMUNE-MEDIATED DERMATITIS 883 0.8760
12 IMMUNE-MEDIATED CYSTITIS 100 0.8696
13 IMMUNE-MEDIATED HEPATIC DISORDER 1683 0.8622
14 IMMUNE-MEDIATED MYASTHENIA GRAVIS 280 0.8615
15 IMMUNE-MEDIATED PANCREATITIS 328 0.8609
16 IMMUNE-MEDIATED ENCEPHALITIS 445 0.8412
17 IMMUNE-MEDIATED MYOCARDITIS 1354 0.8379
18 IMMUNE-MEDIATED LUNG DISEASE 1521 0.8334
19 IMMUNE-MEDIATED HEPATITIS 1665 0.8146
20 IMMUNE-MEDIATED PNEUMONITIS 190 0.8120
21 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 712 0.8109
22 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 181 0.7939
23 FULMINANT TYPE 1 DIABETES MELLITUS 812 0.7876
24 IMMUNE-MEDIATED NEPHRITIS 365 0.7783
25 IMMUNE-MEDIATED ENTEROCOLITIS 2831 0.7691
26 IMMUNE-MEDIATED NEUROPATHY 117 0.7548
27 IMMUNE-MEDIATED ADVERSE REACTION 1126 0.7331
28 TUMOUR HYPERPROGRESSION 181 0.7298
29 AUTOIMMUNE COLITIS 463 0.7178
30 AUTOIMMUNE NEPHRITIS 149 0.6773
31 IMMUNOTOXICITY 77 0.6754
32 HYPOPHYSITIS 1342 0.6667
33 SILENT THYROIDITIS 92 0.6389
34 TUMOUR PSEUDOPROGRESSION 692 0.6320
35 LYMPHOCYTIC HYPOPHYSITIS 170 0.6159
36 LEUKODERMA 118 0.5930
37 AUTOIMMUNE MYOCARDITIS 129 0.5890
38 AUTOIMMUNE HYPOTHYROIDISM 131 0.5504
39 MALIGNANT NEOPLASM OLIGOPROGRESSION 103 0.5176
40 AUTOIMMUNE ARTHRITIS 77 0.4904
41 HYPOPITUITARISM 772 0.4434
42 GLUCOCORTICOID DEFICIENCY 184 0.4350
43 BLOOD CORTICOTROPHIN DECREASED 199 0.4078
44 THYROIDITIS 1188 0.3952
45 SECONDARY ADRENOCORTICAL INSUFFICIENCY 579 0.3832
46 VOGT-KOYANAGI-HARADA DISEASE 84 0.3818
47 THROMBOPHLEBITIS MIGRANS 129 0.3794
48 TUMOUR ASSOCIATED FEVER 143 0.3496
49 MYASTHENIC SYNDROME 238 0.3075
50 PRIMARY ADRENAL INSUFFICIENCY 92 0.3016
51 ADRENAL INSUFFICIENCY 3582 0.2949
52 EOSINOPHILIC FASCIITIS 102 0.2939
53 HYPOTHALAMO-PITUITARY DISORDER 408 0.2800
54 BLOOD CORTICOTROPHIN INCREASED 80 0.2768
55 CORTISOL DECREASED 314 0.2747
56 AUTOIMMUNE PANCREATITIS 135 0.2668
57 LICHENOID KERATOSIS 605 0.2647
58 TYPE 1 DIABETES MELLITUS 1554 0.2578
59 IMMUNE-MEDIATED MYOSITIS 695 0.2519
60 NEPHRITIS 818 0.2447
61 ENCEPHALITIS AUTOIMMUNE 316 0.2403
62 MYOCARDITIS 2706 0.2359
63 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 290 0.2327
64 MALIGNANT NEOPLASM PROGRESSION 22836 0.2228
65 RADIATION PNEUMONITIS 464 0.2166
66 MELANOMA RECURRENT 90 0.2138
67 ADRENAL DISORDER 391 0.2034
68 VITILIGO 474 0.2019
69 CHOLANGITIS SCLEROSING 399 0.1941
70 HYPOTHYROIDISM 6154 0.1925
71 RADIOTHERAPY 365 0.1907
72 PNEUMONITIS 5132 0.1883
73 MYOSITIS 1668 0.1857
74 RADIATION NECROSIS 104 0.1815
75 TUMOUR HAEMORRHAGE 485 0.1698
76 CHOLANGITIS 1039 0.1674
77 AUTOIMMUNE MYOSITIS 78 0.1653
78 LYMPHANGIOSIS CARCINOMATOSA 172 0.1651
79 ENTEROCOLITIS 939 0.1625
80 HYPERTHYROIDISM 2335 0.1611
81 TUMOUR NECROSIS 169 0.1599
82 PARANEOPLASTIC SYNDROME 106 0.1568
83 PEMPHIGOID 1174 0.1554
84 THERAPY PARTIAL RESPONDER 2426 0.1554
85 AUTOIMMUNE HEPATITIS 1033 0.1484
86 TUMOUR RUPTURE 82 0.1459
87 ENCEPHALITIS 1008 0.1456
88 ADRENOCORTICAL INSUFFICIENCY ACUTE 283 0.1449
89 MYASTHENIA GRAVIS 1153 0.1426
90 CYTOKINE STORM 96 0.1401
91 NON-SMALL CELL LUNG CANCER 667 0.1391
92 TUMOUR PAIN 180 0.1366
93 ENDOCRINE DISORDER 168 0.1309
94 METASTATIC MALIGNANT MELANOMA 295 0.1283
95 COLITIS 4839 0.1275
96 SKIN TOXICITY 710 0.1255
97 THYROID HORMONES INCREASED 126 0.1199
98 CANCER PAIN 306 0.1196
99 CYTOMEGALOVIRUS ENTEROCOLITIS 92 0.1195
100 MALIGNANT PLEURAL EFFUSION 199 0.1179
101 VASCULAR ACCESS COMPLICATION 95 0.1173
102 SEROUS RETINAL DETACHMENT 97 0.1158
103 HEPATOCELLULAR CARCINOMA 881 0.1157
104 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 860 0.1145
105 OESOPHAGEAL VARICES HAEMORRHAGE 248 0.1141
106 KERATOACANTHOMA 78 0.1140
107 AUTOIMMUNE HAEMOLYTIC ANAEMIA 391 0.1140
108 LICHEN PLANUS 264 0.1137
109 PULMONARY TOXICITY 771 0.1089
110 SMALL INTESTINAL PERFORATION 204 0.1087
111 IMMUNE THROMBOCYTOPENIA 497 0.1084
112 POLYMYALGIA RHEUMATICA 339 0.1066
113 INTERSTITIAL LUNG DISEASE 5121 0.1057
114 DUODENAL PERFORATION 103 0.1049
115 PROTEINURIA 1992 0.1047
116 HEPATIC CYTOLYSIS 1320 0.1034
117 METASTASES TO ADRENALS 95 0.1029
118 THYROID HORMONES DECREASED 81 0.1013
119 AMYLASE INCREASED 372 0.1007
120 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 175 0.0983
121 HEPATITIS 2461 0.0961
122 AUTOIMMUNE THYROIDITIS 362 0.0957
123 METASTASES TO MENINGES 217 0.0953
124 GUILLAIN-BARRE SYNDROME 456 0.0942
125 TUBULOINTERSTITIAL NEPHRITIS 1739 0.0927
126 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2106 0.0903
127 GASTROINTESTINAL PERFORATION 370 0.0889
128 INFECTIOUS PLEURAL EFFUSION 135 0.0886
129 CACHEXIA 452 0.0878
130 SIALOADENITIS 119 0.0872
131 BILIARY OBSTRUCTION 113 0.0871
132 NON-SMALL CELL LUNG CANCER METASTATIC 76 0.0865
133 FEMALE GENITAL TRACT FISTULA 147 0.0860
134 TROPONIN I INCREASED 143 0.0857
135 METASTASES TO CENTRAL NERVOUS SYSTEM 1102 0.0854
136 SMALL CELL LUNG CANCER 128 0.0847
137 HEPATIC FUNCTION ABNORMAL 3152 0.0844
138 TROPONIN T INCREASED 107 0.0843
139 HYPERSENSITIVITY PNEUMONITIS 95 0.0834
140 FEBRILE BONE MARROW APLASIA 354 0.0832
141 PERIPHERAL MOTOR NEUROPATHY 116 0.0827
142 THYROID DISORDER 1255 0.0813
143 PRERENAL FAILURE 114 0.0809
144 ORGANISING PNEUMONIA 395 0.0796
145 CYTOKINE RELEASE SYNDROME 1593 0.0793
146 BLOOD THYROID STIMULATING HORMONE INCREASED 730 0.0793
147 PULMONARY SARCOIDOSIS 89 0.0793
148 THYROTOXIC CRISIS 89 0.0782
149 LYMPHADENECTOMY 76 0.0779
150 HYPERTRANSAMINASAEMIA 542 0.0779
151 MENINGITIS ASEPTIC 349 0.0777
152 TROPONIN INCREASED 590 0.0775
153 POLYARTHRITIS 395 0.0749
154 DERMATOMYOSITIS 188 0.0741
155 BILE DUCT STENOSIS 88 0.0734
156 LUNG OPACITY 191 0.0724
157 PULMONARY SEPSIS 105 0.0722
158 LYMPHADENOPATHY MEDIASTINAL 138 0.0720
159 CAPILLARY LEAK SYNDROME 148 0.0715
160 DERMATITIS PSORIASIFORM 145 0.0709
161 ENTERITIS 451 0.0704
162 AUTOIMMUNE DISORDER 685 0.0702
163 MYOCARDIAL INJURY 78 0.0693
164 MIXED LIVER INJURY 205 0.0681
165 ERYTHEMA MULTIFORME 625 0.0669
166 BLOOD THYROID STIMULATING HORMONE ABNORMAL 121 0.0656
167 PERIPHERAL SENSORY NEUROPATHY 382 0.0653
168 PHYSICAL DECONDITIONING 166 0.0644
169 BLOOD THYROID STIMULATING HORMONE DECREASED 293 0.0644
170 GASTROINTESTINAL TOXICITY 307 0.0638
171 DUODENITIS 193 0.0628
172 TOXIC EPIDERMAL NECROLYSIS 954 0.0628
173 ASPARTATE AMINOTRANSFERASE ABNORMAL 95 0.0623
174 PANCREATIC FAILURE 110 0.0622
175 POLYMYOSITIS 110 0.0621
176 PERIPHERAL SENSORIMOTOR NEUROPATHY 78 0.0621
177 CARDIAC TAMPONADE 292 0.0614
178 VARICES OESOPHAGEAL 184 0.0608
179 IMMUNE THROMBOCYTOPENIC PURPURA 171 0.0604
180 PNEUMONIA BACTERIAL 550 0.0599
181 LIPASE INCREASED 459 0.0598
182 RHEUMATIC DISORDER 115 0.0594
183 RASH MACULO-PAPULAR 1318 0.0592
184 MYELITIS TRANSVERSE 82 0.0582
185 HYPOALBUMINAEMIA 449 0.0577
186 LARGE INTESTINE PERFORATION 400 0.0575
187 LUNG ADENOCARCINOMA 173 0.0574
188 DIABETIC KETOACIDOSIS 1379 0.0574
189 LUNG ABSCESS 119 0.0567
190 DERMATITIS BULLOUS 406 0.0560
191 MENINGITIS 373 0.0558
192 NEPHROTIC SYNDROME 381 0.0555
193 ASCITES 1621 0.0551
194 THYROID FUNCTION TEST ABNORMAL 229 0.0551
195 BICYTOPENIA 107 0.0545
196 HEPATOTOXICITY 1212 0.0544
197 PORTAL VEIN THROMBOSIS 175 0.0541
198 TASTE DISORDER 1088 0.0536
199 MYELITIS 83 0.0535
200 CELL DEATH 106 0.0534
201 CARCINOEMBRYONIC ANTIGEN INCREASED 103 0.0531
202 EMBOLISM 437 0.0526
203 METASTASES TO LUNG 604 0.0522
204 MYASTHENIA GRAVIS CRISIS 77 0.0519
205 PANCREATIC ENZYMES INCREASED 76 0.0519
206 PNEUMOCYSTIS JIROVECII PNEUMONIA 520 0.0517
207 FEBRILE NEUTROPENIA 3432 0.0517
208 STEROID DIABETES 76 0.0506
209 HEPATITIS FULMINANT 150 0.0505
210 METASTATIC RENAL CELL CARCINOMA 92 0.0502
211 CHRONIC GASTRITIS 113 0.0500
212 MUCOSAL INFLAMMATION 1309 0.0499
213 DRUG ERUPTION 881 0.0497
214 CHOLECYSTITIS 590 0.0495
215 LIVER ABSCESS 160 0.0493
216 GASTRIC PERFORATION 134 0.0491
217 DISSEMINATED INTRAVASCULAR COAGULATION 685 0.0486
218 NEUTROPHIL COUNT DECREASED 1975 0.0484
219 APLASIA PURE RED CELL 166 0.0482
220 TUMOUR LYSIS SYNDROME 424 0.0481
221 HYPERCALCAEMIA 593 0.0480
222 INTENTIONAL PRODUCT USE ISSUE 4187 0.0477
223 CHOLESTATIC LIVER INJURY 105 0.0471
224 LIVER DISORDER 2091 0.0471
225 METASTASES TO PERITONEUM 119 0.0471
226 INTESTINAL PERFORATION 528 0.0470
227 MYELOSUPPRESSION 1667 0.0462
228 MYOCARDIAL NECROSIS MARKER INCREASED 77 0.0459
229 CHOLESTASIS 875 0.0455
230 NEUTROPENIC SEPSIS 324 0.0453
231 ATRIOVENTRICULAR BLOCK COMPLETE 302 0.0451
232 STEVENS-JOHNSON SYNDROME 982 0.0441
233 JAUNDICE CHOLESTATIC 156 0.0441
234 PNEUMOTHORAX 700 0.0441
235 RENAL TUBULAR NECROSIS 432 0.0440
236 METASTASES TO LYMPH NODES 295 0.0437
237 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 166 0.0434
238 CARDIAC DYSFUNCTION 161 0.0432
239 HEPATIC ENCEPHALOPATHY 400 0.0428
240 PERICARDIAL EFFUSION 983 0.0425
241 SMALL INTESTINAL HAEMORRHAGE 85 0.0422
242 ALANINE AMINOTRANSFERASE ABNORMAL 89 0.0422
243 HYDRONEPHROSIS 313 0.0418
244 HEPATIC LESION 180 0.0416
245 PROCTITIS 116 0.0414
246 RECURRENT CANCER 168 0.0411
247 IRIDOCYCLITIS 130 0.0411
248 UVEITIS 558 0.0411
249 HEPATITIS CHOLESTATIC 246 0.0408
250 PLEURAL EFFUSION 2478 0.0407
251 ASPARTATE AMINOTRANSFERASE INCREASED 2142 0.0403
252 HEPATIC FAILURE 1215 0.0403
253 STOMATITIS 2427 0.0400
254 PERFORMANCE STATUS DECREASED 185 0.0396
255 POLYNEUROPATHY 473 0.0395
256 COLITIS MICROSCOPIC 184 0.0388
257 EYELID PTOSIS 392 0.0385
258 PNEUMATOSIS INTESTINALIS 110 0.0385
259 PANCYTOPENIA 2150 0.0384
260 ILEUS 474 0.0381
261 METASTASES TO BONE 624 0.0380
262 GLOMERULONEPHRITIS 93 0.0380
263 DERMATITIS EXFOLIATIVE GENERALISED 132 0.0379
264 URINARY TRACT OBSTRUCTION 90 0.0379
265 FACIAL PARALYSIS 323 0.0379
266 TOXIC SKIN ERUPTION 379 0.0376
267 RENAL TUBULAR ACIDOSIS 82 0.0375
268 OESOPHAGITIS 408 0.0373
269 STRESS CARDIOMYOPATHY 217 0.0373
270 HYPONATRAEMIA 2084 0.0370
271 SKIN DISORDER 1232 0.0369
272 PYELONEPHRITIS 320 0.0369
273 METASTASES TO SPINE 124 0.0369
274 METASTASIS 263 0.0368
275 SARCOIDOSIS 175 0.0368
276 TRANSAMINASES INCREASED 818 0.0368
277 HAEMATOTOXICITY 348 0.0366
278 NEOPLASM PROGRESSION 1272 0.0365
279 SUSPECTED OFF LABEL USE 165 0.0365
280 KERATITIS 111 0.0365
281 ALANINE AMINOTRANSFERASE INCREASED 2231 0.0363
282 NEUROPATHY PERIPHERAL 3409 0.0358
283 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1014 0.0358
284 DUODENAL ULCER 252 0.0357
285 NEPHROPATHY TOXIC 400 0.0356
286 CHOLECYSTITIS ACUTE 199 0.0351
287 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 334 0.0350
288 HEPATITIS TOXIC 91 0.0349
289 THROMBOCYTOPENIA 3905 0.0349
290 PORTAL HYPERTENSION 107 0.0347
291 CYTOPENIA 423 0.0345
292 RENAL TUBULAR DISORDER 97 0.0344
293 HYPOMAGNESAEMIA 479 0.0344
294 RASH MORBILLIFORM 95 0.0342
295 HEPATITIS ACUTE 221 0.0340
296 LUNG CONSOLIDATION 95 0.0339
297 ADENOCARCINOMA 76 0.0339
298 DISEASE PROGRESSION 4010 0.0339
299 ACUTE KIDNEY INJURY 5168 0.0337
300 HYPERBILIRUBINAEMIA 346 0.0334
301 PNEUMONIA ASPIRATION 833 0.0333
302 DRUG-INDUCED LIVER INJURY 1044 0.0332
303 NON-CARDIAC CHEST PAIN 105 0.0332
304 HEPATOCELLULAR INJURY 469 0.0330
305 BLOOD BILIRUBIN INCREASED 893 0.0330
306 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 339 0.0330
307 SYSTEMIC CANDIDA 82 0.0326
308 METASTASES TO LIVER 574 0.0326
309 RENAL IMPAIRMENT 2738 0.0326
310 NEUTROPHIL COUNT ABNORMAL 92 0.0325
311 SUDDEN DEATH 344 0.0325
312 CEREBRAL INFARCTION 794 0.0325
313 CENTRAL VENOUS CATHETERISATION 98 0.0325
314 DIABETES INSIPIDUS 78 0.0324
315 BRAIN OEDEMA 406 0.0321
316 HYPERGLYCAEMIA 1165 0.0319
317 SEPTIC SHOCK 1390 0.0319
318 DECREASED APPETITE 7405 0.0318
319 ERYSIPELAS 160 0.0318
320 CARDIAC FAILURE ACUTE 212 0.0318
321 ORAL FUNGAL INFECTION 87 0.0318
322 FAILURE TO THRIVE 165 0.0317
323 PATHOLOGICAL FRACTURE 160 0.0315
324 HAEMOLYTIC ANAEMIA 280 0.0312
325 DERMATITIS 654 0.0312
326 HAEMOPTYSIS 869 0.0311
327 METASTATIC NEOPLASM 134 0.0310
328 HYPOKALAEMIA 1433 0.0310
329 NEUTROPENIA 4198 0.0308
330 MYOPATHY 266 0.0308
331 PLATELET COUNT DECREASED 3270 0.0306
332 ABDOMINAL INFECTION 78 0.0305
333 NEOPLASM 349 0.0303
334 ACUTE RESPIRATORY FAILURE 583 0.0303
335 PRESCRIBED UNDERDOSE 604 0.0302
336 OESOPHAGEAL STENOSIS 86 0.0302
337 ENCEPHALOPATHY 733 0.0298
338 ANAEMIA 5673 0.0297
339 RADICULOPATHY 78 0.0296
340 BRAIN NATRIURETIC PEPTIDE INCREASED 91 0.0295
341 ATELECTASIS 285 0.0295
342 NEOPLASM RECURRENCE 100 0.0295
343 SKIN EROSION 95 0.0295
344 GLOSSITIS 104 0.0293
345 C-REACTIVE PROTEIN INCREASED 1063 0.0292
346 ADVERSE EVENT 2690 0.0292
347 GENERAL PHYSICAL HEALTH DETERIORATION 3372 0.0291
348 CARDIOTOXICITY 259 0.0290
349 BLOOD ALBUMIN DECREASED 230 0.0290
350 PERIPHERAL ISCHAEMIA 118 0.0289
351 CARDIOMYOPATHY 426 0.0288
352 DERMATITIS ACNEIFORM 175 0.0287
353 PROTEIN URINE PRESENT 143 0.0287
354 HYPERURICAEMIA 117 0.0284
355 RESPIRATORY FAILURE 2072 0.0284
356 APPETITE DISORDER 188 0.0283
357 LUNG DISORDER 1377 0.0281
358 LIVER FUNCTION TEST INCREASED 600 0.0279
359 HYPERKERATOSIS 153 0.0277
360 PAPILLOEDEMA 125 0.0277
361 ACUTE CORONARY SYNDROME 229 0.0276
362 LYMPHOCYTE COUNT DECREASED 488 0.0276
363 PYREXIA 9534 0.0275
364 BLOOD ALKALINE PHOSPHATASE INCREASED 683 0.0275
365 AGRANULOCYTOSIS 510 0.0274
366 EMBOLISM VENOUS 83 0.0273
367 SPINAL CORD COMPRESSION 106 0.0272
368 HYPERTHERMIA 207 0.0271
369 PLEURISY 161 0.0271
370 HOSPICE CARE 267 0.0270
371 VENOUS THROMBOSIS 106 0.0270
372 PULMONARY TUBERCULOSIS 115 0.0269
373 SEPSIS 2970 0.0266
374 VASCULAR DEVICE INFECTION 120 0.0264
375 GAMMA-GLUTAMYLTRANSFERASE INCREASED 585 0.0264
376 BLOOD CREATININE ABNORMAL 91 0.0263
377 DEATH 22537 0.0261
378 SCLERODERMA 95 0.0261
379 ILEUS PARALYTIC 116 0.0260
380 ELECTROLYTE IMBALANCE 299 0.0257
381 LEUKOPENIA 1279 0.0255
382 RENAL CELL CARCINOMA 125 0.0255
383 HYPERPYREXIA 108 0.0255
384 ALTERED STATE OF CONSCIOUSNESS 549 0.0253
385 BILE DUCT STONE 80 0.0251
386 KETOACIDOSIS 188 0.0251
387 HYPOXIA 880 0.0250
388 BACTERAEMIA 296 0.0249
389 OPTIC NEURITIS 226 0.0248
390 SMALL INTESTINAL OBSTRUCTION 306 0.0248
391 PULMONARY MASS 370 0.0248
392 DYSPHONIA 1445 0.0247
393 HYPERTENSION 5202 0.0245
394 CARDIAC FAILURE 1962 0.0244
395 EOSINOPHILIC PNEUMONIA 77 0.0244
396 NECROSIS 136 0.0244
397 EOSINOPHILIA 427 0.0243
398 MALNUTRITION 272 0.0243
399 GENERAL PHYSICAL CONDITION ABNORMAL 164 0.0242
400 SHOCK HAEMORRHAGIC 195 0.0239
401 APLASTIC ANAEMIA 125 0.0239
402 BLOOD CREATINE PHOSPHOKINASE INCREASED 687 0.0238
403 OESOPHAGEAL CANDIDIASIS 95 0.0238
404 ENDOCARDITIS 122 0.0238
405 RASH VESICULAR 115 0.0238
406 BLOOD LACTATE DEHYDROGENASE INCREASED 376 0.0237
407 LYMPHADENOPATHY 839 0.0237
408 PROTEIN TOTAL DECREASED 89 0.0236
409 BRONCHOPULMONARY ASPERGILLOSIS 183 0.0236
410 THROMBOTIC THROMBOCYTOPENIC PURPURA 83 0.0235
411 THROMBOTIC MICROANGIOPATHY 229 0.0235
412 LEFT VENTRICULAR DYSFUNCTION 157 0.0234
413 BLOOD CREATININE INCREASED 1516 0.0232
414 EJECTION FRACTION DECREASED 360 0.0231
415 CUTANEOUS VASCULITIS 84 0.0230
416 GRANULOMA 79 0.0228
417 TRANSFUSION 237 0.0226
418 SKIN REACTION 317 0.0225
419 BLOOD MAGNESIUM DECREASED 194 0.0225
420 EOSINOPHIL COUNT INCREASED 187 0.0224
421 ESCHERICHIA URINARY TRACT INFECTION 95 0.0223
422 BONE LESION 80 0.0222
423 PANCREATITIS 1164 0.0220
424 GENERALISED OEDEMA 272 0.0220
425 PERICARDITIS 369 0.0219
426 FIBRIN D DIMER INCREASED 78 0.0219
427 PULMONARY EMBOLISM 2078 0.0218
428 PULMONARY HAEMORRHAGE 171 0.0218
429 LUNG NEOPLASM 93 0.0218
430 ABDOMINAL ABSCESS 96 0.0217
431 HYPOPHOSPHATAEMIA 160 0.0216
432 BRONCHIOLITIS 76 0.0216
433 INFUSION RELATED REACTION 1425 0.0215
434 TONGUE DISCOMFORT 91 0.0214
435 PRESCRIBED OVERDOSE 414 0.0214
436 LUMBAR VERTEBRAL FRACTURE 98 0.0214
437 ACUTE RESPIRATORY DISTRESS SYNDROME 375 0.0212
438 HYPOCALCAEMIA 401 0.0212
439 IMMUNE SYSTEM DISORDER 279 0.0211
440 CLOSTRIDIUM DIFFICILE COLITIS 223 0.0210
441 STAPHYLOCOCCAL BACTERAEMIA 91 0.0209
442 EXTRAVASATION 86 0.0209
443 PANCREATIC DISORDER 103 0.0209
444 PRODUCT USE IN UNAPPROVED INDICATION 5168 0.0208
445 KIDNEY TRANSPLANT REJECTION 100 0.0208
446 HAEMOGLOBIN ABNORMAL 134 0.0208
447 CARDIOGENIC SHOCK 296 0.0206
448 UROSEPSIS 190 0.0206
449 INFLAMMATORY MARKER INCREASED 102 0.0206
450 GASTRITIS 540 0.0205
451 PURPURA 181 0.0204
452 VASCULITIS 238 0.0204
453 TUMOUR MARKER INCREASED 98 0.0204
454 ISCHAEMIC STROKE 362 0.0203
455 AZOTAEMIA 81 0.0203
456 CORONAVIRUS INFECTION 134 0.0202
457 NEUROTOXICITY 355 0.0202
458 ORAL PAIN 453 0.0202
459 JAUNDICE 536 0.0199
460 DIARRHOEA 12757 0.0197
461 LUNG INFECTION 304 0.0195
462 HEPATIC ENZYME INCREASED 1328 0.0195
463 CHEILITIS 105 0.0194
464 RENAL FUNCTION TEST ABNORMAL 90 0.0194
465 HYPERKALAEMIA 677 0.0193
466 BLOOD SODIUM DECREASED 360 0.0191
467 AORTIC DISSECTION 79 0.0191
468 INTESTINAL ISCHAEMIA 105 0.0190
469 NEUROLOGICAL SYMPTOM 109 0.0190
470 CEREBRAL ISCHAEMIA 98 0.0190
471 FEEDING DISORDER 386 0.0190
472 HICCUPS 156 0.0190
473 HAEMATURIA 649 0.0189
474 ATRIAL FLUTTER 151 0.0189
475 ORAL CANDIDIASIS 245 0.0186
476 HYPOVOLAEMIC SHOCK 89 0.0186
477 LYMPHOEDEMA 128 0.0185
478 PULMONARY ALVEOLAR HAEMORRHAGE 103 0.0183
479 DEHYDRATION 2448 0.0183
480 ACUTE MYELOID LEUKAEMIA 286 0.0183
481 DIABETES MELLITUS 1393 0.0183
482 ATRIOVENTRICULAR BLOCK 141 0.0182
483 MALIGNANT MELANOMA 243 0.0181
484 DEVICE RELATED INFECTION 279 0.0181
485 PNEUMONIA 5848 0.0180
486 RASH 7861 0.0180
487 PARONYCHIA 79 0.0180
488 COVID-19 PNEUMONIA 210 0.0178
489 LUNG INFILTRATION 157 0.0178
490 BONE MARROW FAILURE 361 0.0177
491 UPPER GASTROINTESTINAL HAEMORRHAGE 298 0.0177
492 HYPOPHAGIA 448 0.0175
493 SECOND PRIMARY MALIGNANCY 145 0.0174
494 LIVER INJURY 427 0.0174
495 PRODUCT USE ISSUE 3265 0.0174
496 OFF LABEL USE 15187 0.0173
497 FLANK PAIN 162 0.0173
498 SKIN ULCER 443 0.0171
499 LOCALISED OEDEMA 79 0.0171
500 DELIRIUM 592 0.0170
501 COLITIS ISCHAEMIC 115 0.0170
502 MELAENA 375 0.0170
503 CEREBRAL DISORDER 125 0.0169
504 GASTRIC ULCER 321 0.0169
505 GINGIVITIS 90 0.0167
506 PULMONARY FIBROSIS 317 0.0165
507 GASTROINTESTINAL MOTILITY DISORDER 88 0.0164
508 STAPHYLOCOCCAL SEPSIS 81 0.0164
509 SUPRAVENTRICULAR TACHYCARDIA 157 0.0164
510 INFUSION SITE EXTRAVASATION 102 0.0164
511 ANAL ABSCESS 88 0.0163
512 RENAL DISORDER 760 0.0163
513 HEPATIC ENZYME ABNORMAL 81 0.0162
514 PERITONITIS 336 0.0162
515 RASH PRURITIC 879 0.0162
516 DIPLOPIA 421 0.0162
517 VENOOCCLUSIVE LIVER DISEASE 80 0.0162
518 ACIDOSIS 123 0.0161
519 RESPIRATORY DISTRESS 444 0.0161
520 CONSTIPATION 3489 0.0160
521 DYSPHAGIA 1516 0.0160
522 HEPATIC CIRRHOSIS 300 0.0159
523 ACUTE MYOCARDIAL INFARCTION 469 0.0159
524 ASTHENIA 5956 0.0158
525 GASTRIC ULCER HAEMORRHAGE 87 0.0157
526 CEREBRAL HAEMORRHAGE 562 0.0157
527 PANCREATITIS ACUTE 352 0.0156
528 LYMPHOPENIA 221 0.0156
529 ASPIRATION 171 0.0156
530 OEDEMA 840 0.0155
531 SPINAL COMPRESSION FRACTURE 128 0.0155
532 RENAL FAILURE 2051 0.0154
533 INTESTINAL OBSTRUCTION 581 0.0154
534 DECUBITUS ULCER 125 0.0153
535 ACUTE HEPATIC FAILURE 209 0.0153
536 INCORRECT PRODUCT STORAGE 200 0.0152
537 FEMORAL NECK FRACTURE 78 0.0152
538 GASTROENTERITIS 222 0.0152
539 LEUKOCYTOSIS 275 0.0152
540 LOWER GASTROINTESTINAL HAEMORRHAGE 112 0.0151
541 MOUTH ULCERATION 318 0.0151
542 PLATELET COUNT ABNORMAL 91 0.0150
543 GRAFT VERSUS HOST DISEASE 108 0.0150
544 RETINAL DETACHMENT 138 0.0150
545 DRY MOUTH 1208 0.0149
546 WEIGHT DECREASED 4156 0.0149
547 HYPERTRIGLYCERIDAEMIA 87 0.0148
548 CYTOMEGALOVIRUS INFECTION 246 0.0148
549 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 432 0.0147
550 COMPRESSION FRACTURE 79 0.0147
551 EMPHYSEMA 148 0.0147
552 ATRIAL FIBRILLATION 1414 0.0145
553 BLISTER 815 0.0145
554 MUSCULAR WEAKNESS 1646 0.0145
555 ASPERGILLUS INFECTION 95 0.0145
556 WHITE BLOOD CELL COUNT DECREASED 1566 0.0144
557 BRAIN NEOPLASM 132 0.0144
558 HYDROCEPHALUS 78 0.0143
559 SQUAMOUS CELL CARCINOMA OF SKIN 86 0.0142
560 DIARRHOEA HAEMORRHAGIC 133 0.0142
561 ARTHRITIS 1117 0.0142
562 ORAL DISORDER 104 0.0142
563 FATIGUE 11043 0.0142
564 SINUS TACHYCARDIA 201 0.0141
565 ANAPHYLACTIC SHOCK 362 0.0140
566 APPENDICITIS 131 0.0140
567 THERAPY NON-RESPONDER 628 0.0140
568 DYSPNOEA EXERTIONAL 522 0.0138
569 WHITE BLOOD CELL COUNT ABNORMAL 88 0.0138
570 PIGMENTATION DISORDER 85 0.0138
571 ARTERIOSCLEROSIS CORONARY ARTERY 91 0.0137
572 ATAXIA 163 0.0137
573 CANDIDA INFECTION 231 0.0137
574 SHOCK 313 0.0136
575 RHABDOMYOLYSIS 561 0.0134
576 HEMIPARESIS 225 0.0133
577 BLOOD PRESSURE INCREASED 2021 0.0132
578 HAEMATEMESIS 335 0.0132
579 HYPERTENSIVE CRISIS 146 0.0131
580 BLOOD PRESSURE ABNORMAL 260 0.0131
581 CONJUNCTIVITIS 242 0.0130
582 GINGIVAL PAIN 103 0.0129
583 BLOOD UREA INCREASED 215 0.0128
584 SKIN INFECTION 144 0.0128
585 WEIGHT FLUCTUATION 134 0.0128
586 PAPULE 90 0.0128
587 DEEP VEIN THROMBOSIS 829 0.0127
588 ODYNOPHAGIA 76 0.0127
589 SUBARACHNOID HAEMORRHAGE 129 0.0127
590 AGEUSIA 315 0.0126
591 HAEMOLYSIS 97 0.0125
592 OEDEMA PERIPHERAL 1530 0.0125
593 PULMONARY OEDEMA 561 0.0125
594 NASAL DRYNESS 78 0.0124
595 MYELODYSPLASTIC SYNDROME 180 0.0124
596 NEUTROPHIL COUNT INCREASED 127 0.0124
597 FAECES SOFT 90 0.0124
598 FISTULA 139 0.0124
599 RASH PUSTULAR 90 0.0123
600 SQUAMOUS CELL CARCINOMA 115 0.0122
601 SKIN LESION 335 0.0122
602 INFLAMMATION 622 0.0120
603 EPISTAXIS 899 0.0120
604 ARTERIOSCLEROSIS 113 0.0120
605 GASTROINTESTINAL INFLAMMATION 94 0.0120
606 TRANSPLANT REJECTION 96 0.0120
607 CHILLS 1404 0.0120
608 BLOOD CALCIUM DECREASED 134 0.0119
609 URINARY RETENTION 396 0.0119
610 SPINAL OSTEOARTHRITIS 104 0.0118
611 BLOOD TEST ABNORMAL 166 0.0118
612 SENSITIVE SKIN 87 0.0118
613 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 91 0.0117
614 HAEMORRHAGE INTRACRANIAL 175 0.0117
615 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 301 0.0117
616 EATING DISORDER 249 0.0117
617 MYALGIA 1980 0.0116
618 GASTRIC HAEMORRHAGE 134 0.0116
619 NERVOUS SYSTEM DISORDER 363 0.0116
620 PRODUCT PREPARATION ISSUE 76 0.0116
621 ESCHERICHIA INFECTION 95 0.0115
622 MUSCULOSKELETAL CHEST PAIN 177 0.0114
623 GAIT INABILITY 382 0.0114
624 URINARY TRACT INFECTION 1949 0.0114
625 PARALYSIS 163 0.0114
626 ABDOMINAL PAIN 2640 0.0113
627 VENTRICULAR TACHYCARDIA 187 0.0113
628 HYPOTENSION 2266 0.0113
629 RESPIRATORY TRACT INFECTION 294 0.0113
630 CENTRAL NERVOUS SYSTEM LESION 155 0.0113
631 FACE OEDEMA 190 0.0113
632 SPINAL PAIN 132 0.0113
633 BLOOD DISORDER 90 0.0112
634 PSEUDOMONAS INFECTION 96 0.0112
635 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2015 0.0112
636 CLOSTRIDIUM DIFFICILE INFECTION 243 0.0111
637 EPILEPSY 339 0.0111
638 HAIR COLOUR CHANGES 138 0.0111
639 CELLULITIS 557 0.0110
640 GROIN PAIN 97 0.0110
641 VOMITING 5189 0.0110
642 LIVER FUNCTION TEST ABNORMAL 320 0.0110
643 GINGIVAL BLEEDING 150 0.0110
644 MOUTH HAEMORRHAGE 80 0.0109
645 DYSPNOEA 6173 0.0109
646 POLYURIA 89 0.0109
647 THIRST 194 0.0108
648 RENAL CYST 86 0.0108
649 OXYGEN SATURATION DECREASED 608 0.0108
650 APHONIA 151 0.0108
651 CIRCULATORY COLLAPSE 184 0.0108
652 DRUG RESISTANCE 276 0.0107
653 NODULE 140 0.0107
654 REBOUND EFFECT 121 0.0107
655 PRURITUS 4113 0.0107
656 RASH PAPULAR 239 0.0107
657 ILL-DEFINED DISORDER 646 0.0106
658 FRACTURE 201 0.0106
659 DIVERTICULITIS 293 0.0106
660 APHTHOUS ULCER 82 0.0106
661 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 87 0.0105
662 CARDIO-RESPIRATORY ARREST 431 0.0103
663 GASTROINTESTINAL HAEMORRHAGE 853 0.0102
664 MALAISE 4469 0.0102
665 PRODUCTIVE COUGH 486 0.0102
666 DERMATITIS ALLERGIC 128 0.0102
667 ASPHYXIA 83 0.0102
668 BLOOD PRESSURE FLUCTUATION 242 0.0101
669 SPLENOMEGALY 118 0.0101
670 INFECTION 1453 0.0100
671 DECREASED ACTIVITY 108 0.0100
672 PRODUCT PRESCRIBING ISSUE 218 0.0100
673 NAUSEA 7903 0.0100
674 BONE PAIN 583 0.0099
675 MUSCLE ATROPHY 126 0.0099
676 MYOCARDIAL ISCHAEMIA 113 0.0099
677 IMPAIRED HEALING 324 0.0099
678 OSTEONECROSIS OF JAW 244 0.0099
679 MENTAL STATUS CHANGES 273 0.0098
680 COUGH 2743 0.0098
681 MOTOR DYSFUNCTION 99 0.0097
682 WHITE BLOOD CELL COUNT INCREASED 371 0.0097
683 APHASIA 292 0.0097
684 BACK PAIN 2246 0.0097
685 COLITIS ULCERATIVE 430 0.0096
686 ANAPHYLACTIC REACTION 529 0.0096
687 BLOOD POTASSIUM DECREASED 287 0.0095
688 PHOTOSENSITIVITY REACTION 156 0.0094
689 TYPE 2 DIABETES MELLITUS 318 0.0094
690 ARTHRALGIA 3923 0.0094
691 BLOOD PRESSURE DECREASED 626 0.0094
692 MASS 131 0.0094
693 SEIZURE 1081 0.0093
694 BLOOD CALCIUM INCREASED 82 0.0093
695 NEPHROPATHY 87 0.0093
696 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 509 0.0093
697 DIABETES MELLITUS INADEQUATE CONTROL 163 0.0092
698 DEPRESSED LEVEL OF CONSCIOUSNESS 363 0.0092
699 HAEMOGLOBIN DECREASED 940 0.0091
700 CARDIAC ARREST 748 0.0091
701 DYSURIA 329 0.0089
702 DYSGEUSIA 664 0.0089
703 NAIL DISORDER 78 0.0089
704 BACTERIAL INFECTION 166 0.0089
705 GASTROINTESTINAL DISORDER 795 0.0089
706 HAEMORRHOIDS 173 0.0089
707 BLOOD POTASSIUM INCREASED 144 0.0089
708 NEURALGIA 215 0.0088
709 HERPES ZOSTER 508 0.0088
710 MUSCULOSKELETAL PAIN 463 0.0088
711 FEELING COLD 246 0.0088
712 ANURIA 76 0.0088
713 RED BLOOD CELL COUNT DECREASED 252 0.0088
714 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 457 0.0087
715 METABOLIC ACIDOSIS 280 0.0087
716 HEPATOMEGALY 86 0.0087
717 CONFUSIONAL STATE 1411 0.0087
718 BLOOD PRESSURE SYSTOLIC INCREASED 170 0.0087
719 WOUND INFECTION 95 0.0087
720 IRON DEFICIENCY ANAEMIA 80 0.0087
721 HAEMATOCHEZIA 478 0.0087
722 BODY TEMPERATURE INCREASED 176 0.0086
723 SUBDURAL HAEMATOMA 123 0.0086
724 ARRHYTHMIA 403 0.0085
725 TACHYCARDIA 753 0.0085
726 MOVEMENT DISORDER 272 0.0085
727 VENTRICULAR EXTRASYSTOLES 87 0.0084
728 ORAL DISCOMFORT 116 0.0083
729 CHROMATURIA 188 0.0083
730 TACHYPNOEA 113 0.0083
731 HYPOGLYCAEMIA 402 0.0083
732 ECZEMA 433 0.0083
733 RECTAL HAEMORRHAGE 355 0.0083
734 ADVERSE REACTION 109 0.0082
735 CYSTITIS 260 0.0082
736 HEPATIC STEATOSIS 152 0.0082
737 COGNITIVE DISORDER 379 0.0081
738 THROMBOSIS 649 0.0081
739 RESPIRATORY DISORDER 241 0.0080
740 GLOSSODYNIA 180 0.0080
741 PHARYNGITIS 99 0.0080
742 SCAB 91 0.0080
743 TEMPERATURE INTOLERANCE 82 0.0079
744 STATUS EPILEPTICUS 89 0.0079
745 DYSARTHRIA 296 0.0079
746 RASH ERYTHEMATOUS 375 0.0078
747 COVID-19 1375 0.0078
748 RASH MACULAR 274 0.0078
749 ERYTHEMA 1574 0.0076
750 LUNG NEOPLASM MALIGNANT 313 0.0076
751 DEAFNESS 199 0.0076
752 ULCER 121 0.0076
753 VENTRICULAR FIBRILLATION 84 0.0076
754 TRANSIENT ISCHAEMIC ATTACK 253 0.0075
755 PETECHIAE 78 0.0075
756 DRY SKIN 993 0.0074
757 CHEST PAIN 1372 0.0074
758 ANGINA PECTORIS 212 0.0074
759 LABORATORY TEST ABNORMAL 218 0.0074
760 NEOPLASM MALIGNANT 489 0.0073
761 GLOMERULAR FILTRATION RATE DECREASED 90 0.0073
762 DRY EYE 365 0.0073
763 SYNCOPE 729 0.0073
764 SARS-COV-2 TEST POSITIVE 96 0.0073
765 SKIN EXFOLIATION 612 0.0072
766 RHEUMATOID ARTHRITIS 823 0.0072
767 OSTEOMYELITIS 131 0.0072
768 HAEMORRHAGE 756 0.0072
769 NIGHT SWEATS 232 0.0072
770 INTERNAL HAEMORRHAGE 82 0.0072
771 NO ADVERSE EVENT 1299 0.0072
772 STAPHYLOCOCCAL INFECTION 236 0.0071
773 IMMUNODEFICIENCY 106 0.0071
774 COAGULOPATHY 117 0.0070
775 TOOTH DISORDER 156 0.0070
776 BRONCHOSPASM 100 0.0070
777 NECK PAIN 389 0.0070
778 BRAIN FOG 109 0.0069
779 BLOOD IRON DECREASED 82 0.0069
780 HAEMATOCRIT DECREASED 137 0.0069
781 LOWER RESPIRATORY TRACT INFECTION 312 0.0069
782 FAECES DISCOLOURED 148 0.0068
783 ORTHOSTATIC HYPOTENSION 118 0.0068
784 PULMONARY HYPERTENSION 140 0.0067
785 ALOPECIA 1318 0.0067
786 DEMENTIA 187 0.0067
787 PRODUCT STORAGE ERROR 585 0.0067
788 POST PROCEDURAL COMPLICATION 127 0.0066
789 DYSSTASIA 191 0.0065
790 GENERALISED TONIC-CLONIC SEIZURE 106 0.0064
791 ABSCESS 102 0.0064
792 RIB FRACTURE 131 0.0064
793 LETHARGY 366 0.0064
794 PERIPHERAL SWELLING 977 0.0063
795 LYMPHOMA 98 0.0063
796 CYANOSIS 98 0.0062
797 PULMONARY CONGESTION 82 0.0062
798 DISORIENTATION 246 0.0062
799 HYPOAESTHESIA 929 0.0062
800 HYPERSOMNIA 177 0.0062
801 GAIT DISTURBANCE 1174 0.0061
802 PRESYNCOPE 149 0.0061
803 DRUG INTOLERANCE 587 0.0061
804 ABDOMINAL PAIN UPPER 1242 0.0060
805 BEDRIDDEN 79 0.0060
806 TOXICITY TO VARIOUS AGENTS 1012 0.0060
807 CARPAL TUNNEL SYNDROME 84 0.0060
808 CEREBROVASCULAR ACCIDENT 1006 0.0059
809 POLLAKIURIA 247 0.0059
810 SPEECH DISORDER 310 0.0059
811 GOUT 106 0.0059
812 PLATELET COUNT INCREASED 77 0.0059
813 CHOLELITHIASIS 193 0.0059
814 BLOOD URINE PRESENT 111 0.0058
815 ABDOMINAL DISTENSION 606 0.0058
816 ABDOMINAL PAIN LOWER 146 0.0058
817 BLOOD GLUCOSE ABNORMAL 106 0.0057
818 URINARY INCONTINENCE 169 0.0057
819 PRODUCT PREPARATION ERROR 117 0.0057
820 PAIN IN EXTREMITY 1670 0.0057
821 TOOTHACHE 102 0.0056
822 MUSCULOSKELETAL DISORDER 107 0.0056
823 SPINAL FRACTURE 112 0.0056
824 OROPHARYNGEAL PAIN 517 0.0056
825 ADVERSE DRUG REACTION 500 0.0056
826 DYSPEPSIA 547 0.0056
827 HOSPITALISATION 854 0.0056
828 INCREASED APPETITE 106 0.0055
829 SKIN DISCOLOURATION 254 0.0055
830 UPPER RESPIRATORY TRACT INFECTION 254 0.0055
831 PSORIASIS 713 0.0055
832 SURGERY 317 0.0054
833 PALLOR 146 0.0054
834 INSURANCE ISSUE 82 0.0054
835 CONDITION AGGRAVATED 1630 0.0054
836 SOMNOLENCE 1065 0.0053
837 FULL BLOOD COUNT DECREASED 106 0.0053
838 VERTIGO 320 0.0052
839 POOR QUALITY SLEEP 113 0.0052
840 COLON CANCER 78 0.0052
841 INCORRECT PRODUCT ADMINISTRATION DURATION 113 0.0052
842 ORAL HERPES 101 0.0052
843 FUNGAL INFECTION 172 0.0052
844 CORONARY ARTERY DISEASE 156 0.0051
845 EAR PAIN 100 0.0051
846 HYPOAESTHESIA ORAL 77 0.0051
847 RASH GENERALISED 132 0.0051
848 MYOCARDIAL INFARCTION 885 0.0051
849 JOINT STIFFNESS 131 0.0050
850 PAIN 3059 0.0050
851 INFLUENZA LIKE ILLNESS 409 0.0050
852 CHEST DISCOMFORT 508 0.0050
853 BRADYCARDIA 262 0.0049
854 FREQUENT BOWEL MOVEMENTS 132 0.0049
855 BLINDNESS 199 0.0049
856 BRONCHITIS 361 0.0049
857 LOSS OF CONSCIOUSNESS 623 0.0049
858 BALANCE DISORDER 419 0.0048
859 HAEMATOMA 125 0.0048
860 HEADACHE 3019 0.0048
861 ILLNESS 496 0.0048
862 FALL 1602 0.0048
863 VIRAL INFECTION 160 0.0048
864 PARAESTHESIA 756 0.0048
865 LACRIMATION INCREASED 145 0.0048
866 CATARACT 284 0.0048
867 VISUAL IMPAIRMENT 588 0.0047
868 KIDNEY INFECTION 93 0.0047
869 LIMB DISCOMFORT 146 0.0047
870 FEMUR FRACTURE 145 0.0047
871 CHRONIC KIDNEY DISEASE 354 0.0047
872 GALLBLADDER DISORDER 83 0.0046
873 WOUND 129 0.0046
874 COMA 219 0.0046
875 VISION BLURRED 627 0.0046
876 TREATMENT FAILURE 378 0.0046
877 EYE DISORDER 150 0.0046
878 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 219 0.0046
879 RETCHING 97 0.0045
880 FLATULENCE 258 0.0045
881 HYPERSENSITIVITY 842 0.0045
882 SLEEP DISORDER 313 0.0044
883 ELECTROCARDIOGRAM QT PROLONGED 159 0.0044
884 CARDIOVASCULAR DISORDER 112 0.0044
885 GASTROOESOPHAGEAL REFLUX DISEASE 354 0.0044
886 DISEASE RECURRENCE 204 0.0043
887 BONE DISORDER 78 0.0043
888 UNRESPONSIVE TO STIMULI 109 0.0042
889 VISUAL ACUITY REDUCED 140 0.0042
890 DISCOMFORT 257 0.0042
891 CARDIAC DISORDER 391 0.0042
892 PSORIATIC ARTHROPATHY 169 0.0042
893 SWELLING 389 0.0042
894 THERAPEUTIC RESPONSE UNEXPECTED 186 0.0041
895 SKIN FISSURES 81 0.0041
896 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 294 0.0041
897 HYPOACUSIS 177 0.0041
898 DIZZINESS 2041 0.0041
899 FLUSHING 407 0.0040
900 DEPRESSED MOOD 211 0.0040
901 HIP FRACTURE 128 0.0040
902 CARDIAC FAILURE CONGESTIVE 317 0.0039
903 HEART RATE DECREASED 137 0.0039
904 RHINORRHOEA 252 0.0039
905 LIMB INJURY 105 0.0039
906 INSOMNIA 1029 0.0039
907 PAIN OF SKIN 104 0.0039
908 URTICARIA 647 0.0039
909 RESTLESSNESS 141 0.0038
910 DRUG INEFFECTIVE 5017 0.0038
911 RENAL INJURY 113 0.0038
912 MEMORY IMPAIRMENT 522 0.0038
913 MUSCULOSKELETAL STIFFNESS 326 0.0037
914 TREMOR 616 0.0037
915 THERAPY CESSATION 189 0.0037
916 HEART RATE INCREASED 363 0.0037
917 ARTHROPATHY 203 0.0036
918 HOT FLUSH 275 0.0036
919 LACTIC ACIDOSIS 118 0.0036
920 HEPATIC CANCER 87 0.0036
921 ABDOMINAL DISCOMFORT 606 0.0036
922 INFLUENZA 402 0.0036
923 OSTEONECROSIS 118 0.0036
924 WEIGHT INCREASED 804 0.0036
925 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 120 0.0035
926 JOINT SWELLING 428 0.0035
927 TINNITUS 162 0.0035
928 PAIN IN JAW 99 0.0035
929 MUSCLE SPASMS 637 0.0035
930 PROCEDURAL PAIN 96 0.0035
931 HEAD INJURY 109 0.0034
932 SWOLLEN TONGUE 106 0.0034
933 ANGIOEDEMA 150 0.0034
934 LIP SWELLING 112 0.0034
935 SYSTEMIC LUPUS ERYTHEMATOSUS 119 0.0033
936 SWELLING FACE 216 0.0033
937 FEAR 89 0.0033
938 CONTUSION 316 0.0033
939 GASTRIC DISORDER 112 0.0033
940 FLUID RETENTION 166 0.0033
941 WHEEZING 193 0.0033
942 PRODUCT DOSE OMISSION ISSUE 953 0.0032
943 BLOOD GLUCOSE INCREASED 608 0.0032
944 GASTRIC CANCER 81 0.0032
945 DRUG INTERACTION 507 0.0032
946 HYPERHIDROSIS 409 0.0032
947 GLYCOSYLATED HAEMOGLOBIN INCREASED 80 0.0032
948 MOBILITY DECREASED 227 0.0032
949 DISTURBANCE IN ATTENTION 169 0.0031
950 AMNESIA 203 0.0031
951 FEELING HOT 186 0.0030
952 INTERNATIONAL NORMALISED RATIO INCREASED 86 0.0030
953 HALLUCINATION 226 0.0030
954 MENTAL DISORDER 128 0.0029
955 PALPITATIONS 344 0.0029
956 NASOPHARYNGITIS 540 0.0029
957 ANXIETY 831 0.0029
958 OSTEOARTHRITIS 122 0.0029
959 DEPRESSION 648 0.0028
960 UNDERDOSE 204 0.0028
961 VAGINAL HAEMORRHAGE 121 0.0028
962 THERAPEUTIC RESPONSE DECREASED 168 0.0028
963 NASAL CONGESTION 155 0.0026
964 OSTEOPOROSIS 107 0.0026
965 EYE PAIN 144 0.0025
966 FEELING ABNORMAL 606 0.0025
967 SINUSITIS 256 0.0025
968 THROAT IRRITATION 112 0.0025
969 TREATMENT NONCOMPLIANCE 134 0.0024
970 BURNING SENSATION 170 0.0024
971 PLASMA CELL MYELOMA 93 0.0024
972 BLOOD GLUCOSE DECREASED 113 0.0024
973 OCULAR HYPERAEMIA 111 0.0023
974 NEPHROLITHIASIS 105 0.0023
975 SKIN IRRITATION 102 0.0022
976 AGITATION 159 0.0022
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 152 0.0021
978 THERAPY INTERRUPTED 149 0.0021
979 ACNE 155 0.0020
980 EYE SWELLING 76 0.0020
981 INCORRECT DOSE ADMINISTERED 451 0.0020
982 IRRITABILITY 118 0.0020
983 ASTHMA 210 0.0019
984 PRODUCT DOSE OMISSION 116 0.0018
985 MIGRAINE 128 0.0013
986 BLADDER CANCER 78 0.0013
987 UNEVALUABLE EVENT 92 0.0012
988 MATERNAL EXPOSURE DURING PREGNANCY 101 0.0011
989 BREAST CANCER 97 0.0010
990 PROSTATE CANCER 77 0.0010
991 DRUG DOSE OMISSION 119 0.0007
992 OVERDOSE 149 0.0007
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 136 0.0007